New drug trial aims to tame severe asthma attacks
NCT ID NCT07098403
Summary
This large, late-stage study is testing whether an investigational medicine called SHR-1905 can help adults whose severe asthma is not well-controlled by current standard medications. The main goal is to see if the treatment safely reduces the yearly rate of serious asthma flare-ups that require extra medical care. Researchers will compare results from about 408 participants who receive either the real medicine or a placebo, in addition to their usual asthma treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The First Affiliated Hospital of Guangzhou Medical University
RECRUITINGGuangzhou, Guangdong, 510830, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.